PRONEUROGEN
ProNeurogen is an early-stage biotech company. It is developing novel drug therapeutics to prevent and treat inflammation-induce brain disorders, including: pain, cognitive impairment, memory loss and dementia. ProNeurogen's novel drug technology is based on R&D conducted at the University of Arizona.
PRONEUROGEN
Social Links:
Industry:
Biotechnology
Founded:
2013-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.proneurogen.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API Content Delivery Network Organization Schema Pound Sterling Typekit LocalBusiness Schema Squarespace
Similar Organizations
MouSensor
MouSensor is an early-stage biotech company.
Polgenix
Polgenix is a small biotech company.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company.
Vivo Biosciences
Vivo Biosciences is an early stage biotech company.
Official Site Inspections
http://www.proneurogen.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "ProNeurogen"
ProNeurogen
*These statements have not been evaluated by the Food and Drug Administration. ProNeurogen products are in development and are not intended to diagnose, treat, cure, or prevent any disease.See details»
ProNeurogen - Crunchbase Company Profile & Funding
ProNeurogen is an early-stage biotech company. It is developing novel drug therapeutics to prevent and treat inflammation-induce brain disorders, including: pain, cognitive impairment, …See details»
Leadership — ProNeurogen
Tamara Crockett, Esq Director and IP Advisor. Tamara brings a wealth of experience in technology commercialization, intellectual property, technology transfer, start-ups and early stage commercialization to this project.See details»
ProNeurogen 2025 Company Profile: Valuation, Funding
ProNeurogen was founded in 2013. Where is ProNeurogen headquartered? ProNeurogen is headquartered in Tucson, AZ. What is the size of ProNeurogen? ProNeurogen has 7 total …See details»
Proneurogen, Inc. Company Profile | Tucson, AZ | Competitors ...
Find company research, competitor information, contact details & financial data for Proneurogen, Inc. of Tucson, AZ. Get the latest business insights from Dun & Bradstreet.See details»
ProNeurogen - 2025 Company Profile & Competitors - Tracxn
3 days ago ProNeurogen - Developer of therapeutics to treat vascular dementia and neuropathic pain. Founded by Meredith Hay in the year 2013. ProNeurogen has 565 competitors.See details»
Proneurogen, Inc - VentureRadar
ProNeurogen Peptides are Selective Mas Receptor Agonists: Ang-(1-7) is a member of the Renin-Angiotensin family; Binds to small GPCR Mas receptor; Ang-(1–7) activation of Mas results in …See details»
ProNeurogen, Inc. | Tech Launch Arizona
ProNeurogen, Inc. Year. 2015. ProNeurogen provides treatment and prevention of inflammation-related brain disorders. This includes cognitive impairment and memory loss associated with …See details»
About — ProNeurogen
Vision: To be the global leader in protecting brain health of millions by developing life-changing therapies to treat cognitive impairment associated with neurodegenerative diseases. …See details»
PRONEUROGEN INC Overview | SignalHire Company Profile
Organization Website: proneurogen.com : PRONEUROGEN INC industries Pharma: Headquarters Location: 1970 N Wentworth Rd, Tucson, Arizona, US 1970 N Wentworth ...See details»
ProNeurogen - Products, Competitors, Financials, Employees ...
ProNeurogen is an early-stage biotech company focused on developing novel peptides for cognitive and memory deficits due to brain inflammation. The company's main offerings …See details»
PRONEUROGEN INC - LinkedIn
ProNeurogen is an early-stage biotech company. It is developing novel drug therapeutics to prevent and treat inflammation-induce brain disorders, including: pain, cognitive impairment, …See details»
UA Startup ProNeurogen Advances New Therapies for Vascular …
The patents, both licensed to ProNeurogen, serve as the cornerstone for ProNeurogen’s drug development program. “There is a great and rapidly growing human need for therapies to treat …See details»
Copy of About — ProNeurogen
Our Mission: To develop drug therapies for preventing and treating cognitive impairment and pain caused by inflammation.. Brain Inflammation: Pain, cognitive impairment and memory loss …See details»
ProNeurogen - Tech Stack, Apps, Patents & Trademarks
Jan 13, 2025 Organization. ProNeurogen . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 18. Monthly …See details»
ProNeurogen - Overview, News & Similar companies - ZoomInfo
ProNeurogen is an early-stage biotech company. It is developing novel drug therapeutics to prevent and treat inflammation-induce brain disorders, including: pain, cognitive impairment, …See details»
Proneurogen Inc | www.inknowvation.com
ProNeurogen's PNA-5 drug candidate improves the effects of the Angiotensin-(1-7) peptide by moving it across the blood-brain-barrier, increasing its half-life and improving its stability. …See details»
PIPELINE — ProNeurogen
Proneurogen therapeutic platform pipeline we are developing a platform of drug candidates that have the potential to improve patient’s lives by targeting the underlying causes of vascular and …See details»
ProNeurogen’s New Drug Candidate Shows Promise For
Mar 4, 2019 ProNeurogen’s PNA-5 drug candidate improves the effects of the Angiotensin-(1-7) peptide by moving it across the blood-brain-barrier, increasing its half-life and improving its …See details»
News — ProNeurogen
Proneurogen neuroprotective peptide ind application for pna1 gets go-ahead from fda for phase ii study in cardiac bypass patients. aug 2015. proneurogen signs exclusive license with the …See details»